The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites
MHC class I-related protein (MR1) presents vitamin B-based antigens (Ags) to mucosal-associated invariant T (MAIT) cells. While microbial riboflavin (RF) precursors are well-documented MR1 ligands, it is unclear whether host-generated RF catabolites influence MR1 immunity. Here, we report that RF catabolites, including 10-formylmethylflavin (FMF), lumichrome, lumiflavin, and alloxazine, bind to MR1 with moderate affinity, while RF itself binds weakly. In contrast to the MR1-upregulating microbial RF precursors, RF catabolites reduced the surface level of MR1 by inducing its retention in the endoplasmic reticulum and inhibiting exit. These RF catabolites weakly competed with vitamin B-based Ags for MR1 binding, thereby selectively inhibiting MAIT activation. The crystal structures of MR1 with RF, FMF, lumiflavin, and lumichrome show binding in the A'-pocket of MR1. Here, lumichrome formed a "flavin bond" covalent interaction with MR1-Lys43 differing from the typical Schiff base. Collectively, we identified three-ringed isoalloxazines that bind MR1 and reduce surface levels, suggesting a potential role in dampening MAIT cell immunity.
Authors
- Jóse A. Villadangos (ORCID: https://orcid.org/0000-0001-6771-8891)
- Nicholas A. Gherardin (ORCID: https://orcid.org/0000-0003-4690-2571)
- Wael Awad (ORCID: https://orcid.org/0000-0002-7597-2133)
- Mitchell P. McInerney (ORCID: https://orcid.org/0009-0001-1411-3650)
- Mohamed R. Abdelaal (ORCID: https://orcid.org/0000-0001-9804-1510)
- Hamish E. G. McWilliam (ORCID: https://orcid.org/0000-0003-3479-3419)
- Jamie Rossjohn (ORCID: https://orcid.org/0000-0002-2020-7522)
- Anthony W. Purcell (ORCID: https://orcid.org/0000-0003-0532-8331)
- Jieru Deng (ORCID: https://orcid.org/0000-0002-7786-4961)
- E. Ito (ORCID: https://orcid.org/0009-0001-0785-0679)
- Sho Yamasaki (ORCID: https://orcid.org/0000-0002-5184-6917)
Institutions
- The University of Melbourne (AU)
- Discovery Institute (US)
- Peter Doherty Institute (AU)
- Institute of Infection and Immunity (CA)
- Monash University (AU)
- The University of Osaka (JP)
Publication Details
- Journal
- The Journal of Experimental Medicine
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1084/jem.20250711
- Citations
- 1
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Australian Nuclear Science and Technology Organisation
- Australian Cancer Research Foundation
- Australian Synchrotron